| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/25/2012 | CN101461803B Use of grape inner ester |
| 01/25/2012 | CN101456841B Amide derivative and medicine |
| 01/25/2012 | CN101429187B Ketone compound, preparation method and application thereof |
| 01/25/2012 | CN101410393B Novel heteroaryl substituted benzothiazoles |
| 01/25/2012 | CN101379064B Trihydrochloride forms of a dihydropteridinone derivative and processes for preparation |
| 01/25/2012 | CN101365778B Cleaning composition |
| 01/25/2012 | CN101361774B Combination containing brown alga polysaccharide sulfuric ester and panax ginseng and use thereof |
| 01/25/2012 | CN101341160B Process for production of water-soluble azole prodrug |
| 01/25/2012 | CN101278967B Health care capsules for overall regulating immunity of organism and preparation technique |
| 01/25/2012 | CN101269067B Antibacterial gynecology externally used pharmaceutical combination |
| 01/25/2012 | CN101269049B Phosphoric acid ligustrazine micropore permeation pump control-release tablet and preparation method thereof |
| 01/25/2012 | CN101244122B Pharmaceutical combination |
| 01/25/2012 | CN101242823B Composition comprising oleic acid and the use thereof |
| 01/25/2012 | CN101167811B External-applied preparation with anti-inflammation, itching-relieving and sterilization function and manufacturing method and application thereof |
| 01/25/2012 | CN101143135B Melatonin orally disintegrating tablet and preparation method thereof |
| 01/25/2012 | CN101119995B Non steroidal glucocorticoid receptor modulators |
| 01/25/2012 | CN101119991B Salt of proline derivative, solvate thereof, and production method thereof |
| 01/25/2012 | CN101098692B Therapeutic compounds isolated form CALOMERIA AMARANTHOIDES |
| 01/25/2012 | CN101085355B 5-flucytosine/hydrotalcite-like nano hybrid compound and preparation method thereof |
| 01/25/2012 | CN101031295B Medicinal composition for prevention or treatment of parasitic protozoan infection |
| 01/24/2012 | US8101799 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds |
| 01/24/2012 | US8101795 Process for preparing high purity corosolic acid and high purity ursolic acid |
| 01/24/2012 | US8101794 Crystalline forms of a 3-carboxypropyl-aminotetralin compound |
| 01/24/2012 | US8101793 Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 01/24/2012 | US8101791 Aminotetralin compounds as mu opioid receptor antagonists |
| 01/24/2012 | US8101783 Titanium-maltol compound and method of synthesizing the same |
| 01/24/2012 | US8101781 Process for the preparation of highly optical pure carvedilol |
| 01/24/2012 | US8101778 Five-membered heterocycles useful as serine protease inhibitors |
| 01/24/2012 | US8101775 Indole derivatives as S1P1 Receptor |
| 01/24/2012 | US8101774 Ester derivatives and medicinal use thereof |
| 01/24/2012 | US8101773 Hydroxy methyl phenyl pyrazolyl urea compounds useful in the treatment of cancer |
| 01/24/2012 | US8101770 Pyridones useful as inhibitors of kinases |
| 01/24/2012 | US8101765 Process for preparing acyclic HCV protease inhibitors |
| 01/24/2012 | US8101761 (E)-N-{3-[1-(8-fluoro-11H-10-OXA-1-AZA-dibenzo [A,D] cyclohepten-5ylidene)-propyl]-phenyl}-methanesulfonamide as glucocorticoid receptor modulator for the treatment of rheumatoid arthritis |
| 01/24/2012 | US8101760 Glucocorticoid receptor modulator and methods of use |
| 01/24/2012 | US8101754 e.g., 2-tert-Butyl-4-{4-[3-(4-methyl-5-methyl-4H-[1,2,4]triazol-3-ylsulfanyl)-propyl]-piperazin-1-yl}-6-(1-methylcyclopropyl)-pyrimidine hydrochloride; central nervous system disorders; schizophrenia; antidepressant, anxiolytic agent, cognition activator; Parkinson's and Alzheimer's diseases |
| 01/24/2012 | US8101751 Reverse-turn mimetics and method relating thereto |
| 01/24/2012 | US8101742 Method and medicament for inhibiting the expression of a given gene |
| 01/24/2012 | US8101733 Methods of evaluating mixtures of polysaccharides |
| 01/24/2012 | US8101666 Methods and compounds for detection of medical disorders |
| 01/24/2012 | US8101665 Process for synthesis of tritiated and deuterated thiorphan and acetorphan |
| 01/24/2012 | US8101664 Propellants; aerosols; skin disorders |
| 01/24/2012 | US8101663 Polymorphs of suberoylanilide hydroxamic acid |
| 01/24/2012 | US8101662 Treatment of cancer with specific RXR agonists |
| 01/24/2012 | US8101661 Polar hydrophilic prodrugs and non-standard amino acid conjugates of amphetamine and other stimulants and processes for making and using the same |
| 01/24/2012 | US8101660 2-(acetyloxy)-5-hydroxybenzenesulfonic acid, or 5-(acetyloxy)-2-hydroxybenzene-sulfonic acid, or 2,5-bis(acetyloxy)benzenesulfonic acid, or sultosilic acid for example; combination therapy with other drugs or photodynamic therapy |
| 01/24/2012 | US8101659 Methods of treatment and pharmaceutical composition |
| 01/24/2012 | US8101658 Nitric oxide donating prostamides |
| 01/24/2012 | US8101655 Fluorescent dyes and complexes |
| 01/24/2012 | US8101653 Therapeutic compositions |
| 01/24/2012 | US8101652 For therapy of neoplastic diseases |
| 01/24/2012 | US8101651 Compounds with activity at estrogen receptors |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101649 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors |
| 01/24/2012 | US8101648 Hydroxybenzamide derivatives and their use as inhibitors of HSP90 |
| 01/24/2012 | US8101647 Spiro-oxindole compounds and their use as therapeutic agents |
| 01/24/2012 | US8101646 Amorphous form of an L-arginine salt of perindopril and processes for preparation thereof |
| 01/24/2012 | US8101645 Thienopyrroles and pyrrolothiazoles as new therapeutic agents |
| 01/24/2012 | US8101644 Pyrrolinone derivative and pharmaceutical composition comprising the same |
| 01/24/2012 | US8101643 Benzimidazole derivatives |
| 01/24/2012 | US8101642 3-substituted propanamine compounds |
| 01/24/2012 | US8101641 Such as 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-2-hydroxybenzoic acid for modulating premature translation termination or nonsense-mediated mRNA decay in cells |
| 01/24/2012 | US8101640 Antibacterial agents |
| 01/24/2012 | US8101639 6-oxo-1,6-dihydropyridine compounds as inhibitors of MEK and methods of use thereof |
| 01/24/2012 | US8101638 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/24/2012 | US8101637 Alkynyl derivatives as modulators of metatropic glutamate receptors |
| 01/24/2012 | US8101636 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 01/24/2012 | US8101635 Use of glutamate antagonists which is a NMDA receptor antagonist ( ifenprodil, memantine) to reduce or control retinal pigment epithelium and/or glial migration and the subsequent development of proliferative vitreoretinopathy ( vision defect ) |
| 01/24/2012 | US8101634 Bicyclic compounds and use as antidiabetics |
| 01/24/2012 | US8101633 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects |
| 01/24/2012 | US8101632 5-furopyridinone substituted indazoles |
| 01/24/2012 | US8101630 Extended release opioid abuse deterrent compositions and methods of making same |
| 01/24/2012 | US8101629 Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 01/24/2012 | US8101627 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
| 01/24/2012 | US8101626 GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto |
| 01/24/2012 | US8101625 Pyrimidinones as Casein Kinase II (CK2) modulators |
| 01/24/2012 | US8101624 Quinazoline derivatives |
| 01/24/2012 | US8101623 Substituted pyrrolo[2,3-d]pyrimidine as a protein kinase B inhibitor |
| 01/24/2012 | US8101622 Pyridopyrimidinone inhibitors of PI3Kα and mTOR |
| 01/24/2012 | US8101620 Heterocyclic sulfonamides |
| 01/24/2012 | US8101619 Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition |
| 01/24/2012 | US8101618 1,4-substituted piperazine derivatives |
| 01/24/2012 | US8101617 Disubstituted ureas and uses thereof in treating heart failure |
| 01/24/2012 | US8101616 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 01/24/2012 | US8101615 Chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction, heart failure |
| 01/24/2012 | US8101614 Substituted pyrrolo [1,2-a] pyrazines as calcium channel blockers |
| 01/24/2012 | US8101613 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 01/24/2012 | US8101612 N-3-isoxazolyl-4-methyl-3-(1-((1-methylethyl)oxy)-6-phthalazinyl)benzamide; p38 kinase inhibitor; antiinflammatory, analgesic agent; rheumatoid arthritis, osteoporosis, leukemia, psoriasis, Crohn's disease, rhinitis, ulcerative colitis, dermatitis, asthma, Alzheimer's disease, type I and II diabetes |
| 01/24/2012 | US8101611 Substituted pyridazines inhibitors of MEK |
| 01/24/2012 | US8101610 Bisamide inhibitors of hedgehog signaling |
| 01/24/2012 | US8101609 Processes for the preparation of rivaroxaban and intermediates thereof |
| 01/24/2012 | US8101608 Compounds and compositions as protein kinase inhibitors |
| 01/24/2012 | US8101607 Pharmaceutical compounds |
| 01/24/2012 | US8101606 Neurofibromin pathway modulators |
| 01/24/2012 | US8101605 SHIP1 modulators and methods related thereto |
| 01/24/2012 | US8101604 Alpha carbolines and uses thereof |
| 01/24/2012 | US8101603 Tyrosine kinase inhibitors |
| 01/24/2012 | US8101602 Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors |
| 01/24/2012 | US8101601 Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders |
| 01/24/2012 | US8101600 Method of treating depression |